Author(s): Sisode Pranali S, Jain Vinit C., Prajapati Neelam

Email(s): pranalisisode19@gmail.com

DOI: 10.5958/2231-5659.2016.00009.6   

Address: Sisode Pranali S.*, Dr. Jain Vinit C., Prajapati Neelam
Department of Quality Assurance, Shree Dhanvantary Pharmacy College, Kim, Dist. Surat, Gujarat.
*Corresponding Author

Published In:   Volume - 6,      Issue - 1,     Year - 2016


ABSTRACT:
This review article presents the pharmacology of combined treatment of Saxagliptin hydrochloride and Glibenclamide therapy especially in type-2 diabetes. Saxagliptin hydrochloride is anti diabetic agent (dipeptidyl peptidase-4 inhibitor). Glibenclamide is also an anti-diabetic agent. If Glibenclamide is administered as a long term treatment and also in large quantities, the condition of patient becomes worse by causing sulphonylurea failure. And also occurrence of adverse effect of weight gain and hypoglycemia. The availability of newer agents such as dipeptidyl peptidase-4 inhibitors may allow for additional therapeutic combinations to improve glycaemic control without increasing the risk of adverse effects. Combination therapy of a DPP-4 inhibitor with a sub maximal dose of a sulphonylurea represents an alternative treatment approach that may provide improved glycaemic control earlier in the disease course and allow the use of lower doses of sulphonylurea to reduce the risk for dose-related adverse events. Combination therapy mainly used to treat patient having sulphonylurea failure. The mechanism of action of Saxagliptin hydrochloride and Glibenclamide is quite different. Saxagliptin hydrochloride inhibits the dpp-4 enzyme and promotes insulin synthesis and release. While Glibenclamide stimulation of insulin release from the B2 cells of the pancreas by blocking the ATP-sensitive k+ channels. The combination of both have decrease dose and improve the glycemic control. Combination of both the drugs were approved by us government and has been used in type-2 diabetes (diabetes mellitus). The main objective of this review article is to provide pharmacological information of combined therapy of saxagliptin hydrochloride and glibenclamide to researcher in development of combined dosage form of this.


Cite this article:
Sisode Pranali S, Jain Vinit C., Prajapati Neelam. Pharmacology of Combined Treatment of Saxagliptin Hydrochloride and Glibenclamide Therapy to treat Type-2 Diabetes. Asian J. Res. Pharm. Sci. 6(1): Jan.-Mar., 2016; Page 59-61. doi: 10.5958/2231-5659.2016.00009.6


Recomonded Articles:

Author(s): S. S. Shuka, Bina Gidwani, R. Pandey, S. P. Rao, V. Singh, Amber Vyas

DOI:         Access: Open Access Read More

Author(s): Pratibha Gavarkar, Pramod Patil, Akshay Sutar, Shridhar Rasal, Dyaneshwar Surwase

DOI: 10.5958/2231-5659.2016.00029.1         Access: Open Access Read More

Author(s): Sunity Singh, Himanshu Joshi

DOI:         Access: Open Access Read More

Author(s): D.M. Shinkar, Aarif S. Khatik, R.B. Saudagar

DOI: 10.5958/2231-5659.2016.00022.9         Access: Open Access Read More

Author(s): Debarshi Kar Mahapatra, Ruchi S. Shivhare, Sayan Dutta Gupta

DOI: 10.5958/2231-5659.2018.00006.1         Access: Open Access Read More

Author(s): Chinedu Fred Anowi, Uyai Umanah, A.U. Emezie, AU Utoh-Nedosa

DOI:         Access: Open Access Read More

Author(s): Satheesh Kumar. G, Noorjahan, G. Sadhana Reddy, Syed Khundmeer Mujahid, T. Ashwini, V. Mahender Chary

DOI: 10.5958/2231-5659.2018.00041.3         Access: Closed Access Read More

Author(s): Nikita R. Nikam, Rohan R. Vakhariya, Dr. C. S. Magdum

DOI: 10.5958/2231-5659.2019.00016.X         Access: Closed Access Read More

Author(s): D. D. Rishipathak, A. B. Kokate, K. S. Madhawai

DOI: 10.5958/2231-5659.2017.00032.7         Access: Open Access Read More

Author(s): Sarmistha Rej, Madhurima Dutta, Shahid Jamal, Sumanta Das ,Sabyasachi Chatterjee

DOI:         Access: Open Access Read More

Author(s): Srikanth Jupudi, Padmini K., Jaya Preethi P., Deepak Bharadwaj P.V.P., Vengal Rao P.

DOI:         Access: Open Access Read More

Author(s): Usama Shoukath, Umama Shoukath, Salma Sultana, Mohammed Nayeem Uddin

DOI: 10.5958/2231-5659.2018.00014.0         Access: Open Access Read More

Author(s): Goli.Venkateshwarlu, Ragya Eslavath, Santhosh. Anasuri, Gutha.Suma, Kasireddy.Swapna, E.Rajeshwari

DOI:         Access: Open Access Read More

Author(s): A. Elumalai, M. Chinna Eswaraiah, Karisha Madhavi Lahari, Hamed Ali Shaik

DOI:         Access: Open Access Read More

Author(s): Goli Venkateshwarlu, Ragya Eslavath, Santhosh Anasuri, Gutha Suma, Kasireddy Swapna, Ramesh

DOI:         Access: Open Access Read More

Asian Journal of Research in Pharmaceutical Sciences (AJPSci) is an international, peer-reviewed journal, devoted to pharmaceutical sciences....... Read more >>>

RNI: Not Available                     
DOI: 10.5958/2231-5659 


Recent Articles




Tags